Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0005 |
mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |